Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-297817 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 8, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
150,000
Total Value
$6,054,000.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 7, 2026 | Exercise/Conversion | 50,000 | $2.08 | $104,000.00 | 716,568 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 7, 2026 | Sale | 50,000 | $119.00 | $5,950,000.00 | 666,568 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 7, 2026 | Exercise/Conversion | 45,559 | $0.00 | $0.00 | 90,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jul 7, 2026 | Exercise/Conversion | 4,441 | $0.00 | $0.00 | 14,284 | Direct | โ | View Details |